Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke that
is increasingly being treated with percutaneous transluminal angioplasty and stenting (PTAS…

Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke.
Warfarin is commonly used in preference to aspirin for this disorder, but these therapies have …

Our goal in this review is to discuss the pathophysiology, diagnosis, and treatment of stroke
caused by atherosclerosis of the major intracranial arteries. References for the review were …

intermediate-(30 days to 2 years), and long-term risk were examined from recent studies
conducted primarily in US and European populations. Estimates of short-term risk can be …

Intracranial atherosclerosis is one of the most common causes of stroke worldwide and is
associated with a high risk of recurrent stroke. New therapeutic approaches to treat this high-…

The aim of this updated guideline is to provide comprehensive and timely evidence-based
recommendations on the prevention of future stroke among survivors of ischemic stroke or …

Background— Antithrombotic therapy for intracranial arterial stenosis was recently evaluated
in the Warfarin versus Aspirin for Symptomatic Intracranial Disease (WASID) trial. A …

BACKGROUND AND PURPOSE: Atherosclerosis of the major intracranial arteries is an
important cause of ischemic stroke. We established measurement criteria to assess percent …

• We performed postmortem magnetic resonance imaging and pathologic examinations on
the brains of seven consecutive patients older than 50 years of age who died of …

Background Early results of the Stenting and Aggressive Medical Management for Preventing
Recurrent stroke in Intracranial Stenosis trial showed that, by 30 days, 33 (14·7%) of 224 …